                                                                   1
中文摘要 
 
    本研究利用電紡織技術(electrospinning)，製備出高多孔性且表面積大之幾丁聚醣(chitosan) 奈米纖
維膜、蠶絲蛋白(silk fibroin)/幾丁聚醣(50/50)複合式奈米纖維膜、及蠶絲蛋白奈米纖維膜。掃描式電子
顯微鏡(SEM)結果顯示，纖維直徑分別為 317 ± 109，447 ± 167以及 399 ± 184 nm。奈米纖維膜之材料
物性，由傅立葉轉換紅外線光譜儀(FT-IR)及 X 光射線繞射(XRD)分析。本實驗以人類間葉幹細胞
( human mesenchymal stem cell)植入奈米纖維膜上，以活體外(in vitro)實驗探討細胞貼覆及生長生物相
容性研究，及分析幹細胞分化為骨母細胞之效果。其實驗結果顯示，幹細胞於蠶絲蛋白/幾丁聚醣(50/50)
複合式奈米纖維膜上，與幾丁聚醣奈米纖維膜相較下，有著良好的細胞貼附及生長；與蠶絲蛋白奈米
纖維膜比較下，具有相當不錯之骨母細胞分化能力。此外，幹細胞於複合式奈米纖維膜之細胞礦化
(mineralization)分析及細胞型態，分別以 SEM 及 live/dead 來探討。能量分散光譜儀(EDS)分析顯示，
幹細胞於蠶絲蛋白/幾丁聚醣(50/50)複合式奈米纖維膜上礦化表現，明顯的比幾丁聚醣及蠶絲蛋白奈米
纖維膜都高，培養 14 天後，幹細胞於蠶絲蛋白/幾丁聚醣(50/50)複合式奈米纖維膜上之鈣磷比趨近於
1.6。裸鼠活體內(in vivo)試驗結果顯示，蠶絲蛋白/幾丁聚醣(50/50)複合式奈米纖維膜確實具有高度的
生物相容性。綜合以上結果，本研究所製備出之蠶絲蛋白/幾丁聚醣(50/50)複合式奈米纖維膜，可提供
硬骨細胞較穩定且合適的生長空間，於硬骨組織工程上極具潛力。 
關鍵詞：電紡織法、幾丁聚醣、蠶絲蛋白、人類間葉幹細胞、硬骨組織工程 
 
 
 
 
 
 
 
 
 
 
 
                                                                   3
文獻探討 
 
硬骨之生理結構與功能 
    硬骨是特化的結締組織，具有細胞間鈣化物質(硬骨基質, bone matrix)以及具造血功能之骨髓和具
有營養傳遞及增生骨層以使受損骨組織行癒合及再生作用的骨膜。硬骨是由有機物和無機物組成，其
中有機物約佔整體乾重的 30%左右，主要是由第一型膠原蛋白所構成，使硬骨具有一定的韌度；而無
機物約佔 70%的乾重，主要是鈣質和磷質，使硬骨具有一定的硬度。所以，骨骼同時具有韌度又有硬
度，可構成骨架，具有支撐身體重量、保護內部器官等功能。骨骼也可與骨骼肌、肌腱、韌帶和關節
產生作用，並傳遞力量使身體運動。此外，骨骼也是造血的重要器官和鈣、磷、鎂、鈉等離子的儲存
和釋放的重要場所。對於人體骨骼的組成成份而言，主要是由大量的細胞間質包圍散布於其中之骨細
胞所組成，細胞間質的主要組成物為佔骨骼乾重 75%的無機鹽類(inorganic salt)、25%的有機基質
(organic matrix)和大量的水份，因此，骨骼本身即是一種極為完美的複合材料，且由於細胞間質具有
大量的鈣鹽沈積，形成很堅硬的組織，構成身體的骨骼系統。在無機鹽類的組成物中，最主要是由未
完全結晶的缺鈣氫氧基磷灰石(calcium-deficient HAP)所構成；而有機基質則為網狀構造，主要包括大
約 90~95%的膠原蛋白(collagen)、1%的葡萄糖胺聚合醣(glycosaminoglycan)以及 5%左右的其他蛋白質。 
 
骨細胞與骨骼重建機制 
    骨骼中主要含有三種型式的細胞，分別為骨母細胞(osteoblast)、成骨細胞(osteocyte)、及蝕骨細胞
(osteoclast)，新生骨組織在形成的過程中，是經由特定型態的細胞來進行骨骼的模化(shaped)和重塑。
其中新骨的形成是經由骨母細胞完成，而舊骨的吸收及移除則是由蝕骨細胞負責，至於成骨細胞則對
骨母細胞及蝕骨細胞兩者的活性具有間接協調的功能。骨母細胞是促使骨骼重建的特殊細胞，乃由結
締組織中的間葉細胞(mesenchymal cell)分化而來，其中必須先經過骨髓網狀細胞(reticulated cells of 
bone marrow)及骨前趨細胞(osteoprogenitor cell)兩個過渡的細胞型態，其主要功能為形成彈性蛋白、合
成膠原纖維及參與鈣化。在骨形成的過程中，存在於間葉細胞區的巨大細胞(可能為 osteoblast)一開始
是被膠原纖維圍繞住，然後逐漸連結在一起而形成一段段未鈣化的骨基質，此稱為類骨質(osteoid)，
這些類骨質段接著進行骨礦化步驟，此時的骨母細胞並轉化為成骨細胞。所以在骨形成與骨鈣化的步
驟中，骨母細胞扮演著主要的角色，而且因骨母細胞無論在酸性或鹼性環境下均具有磷酸脢活性，因
此可利用鹼性磷酸酵素(alkaline phosphatase)的測定，來判斷骨母細胞介入鈣化步驟的情況。 
    成骨細胞是骨組織中細胞轉化達到最後穩定型態的活細胞，當骨母細胞經過製造骨基質活性期
後，大部份又回到不活化狀態，變成扁平紡錘狀並貼近不活化的骨表面，但有一些骨母細胞則被正在
鈣化的骨基質所包圍而存在於骨窩中，稱為成骨細胞。成骨細胞可以依賴在骨小管中的細胞質突起傳
輸養分，而且每個成骨細胞周圍均有一薄層骨質圍繞，並保留其親代骨母細胞的高基氏體(golgi 
                                                                   5
織工程此技術，以解決當時移植器官不足等問題。而組織工程為生命科學與工程科學所發展出來之一
門科學，其目的來修復、維持或改善人體組織的功能，而此取代物將成為病人身體的一部分，對疾病
可提供特定的醫療，也就是移植具有正常或類似功能的人工組織或器官於損傷處，以期能夠達到修復
的目的。 
    組織工程運用工程學和生命科學的基本原理，來恢復維持或改善受損組織或器官功能的生物替代
物，因此它是一門集現代生命科學、臨床醫學、生物工程、材料科學及工程學於一體，而發展起來的
學科。組織工程的核心概念中，有三個基本要素：細胞(cell)、支架(scaffold)、和訊息因子(signal)。(1)
細胞：在骨組織工程上，必須找到能產生骨骼的細胞。(2)支架：能攜帶成骨細胞的材料。這些材料在
填補骨缺損的位置之後，能使成骨細胞貼附、移行、分化與繁殖。具有這種性質的材料，稱之為具有
骨傳導(osteoconduction)性質。(3)訊息因子：意即在植入含有骨細胞的支架外，再提供一些具生物活性
的因子，如生長因子，來更進一步促進成骨細胞之繁殖、分化，並維持產生骨頭的顯型。因此，針對
體內硬骨組織的需求，適當結合支架、細胞、訊息因子三大要素，進行細胞增生與分化，並促使細胞
正確地分泌胞外基質，以完成硬骨組織修復的程序，為硬骨組織工程研究上，大家一直努力的方向。 
 
骨組織工程-細胞 
    於硬骨組織工程中細胞的來源大多以骨母細胞與骨髓間葉幹細胞為主要的研究對象；骨組織中包
含骨母細胞(osteoblast)、骨細胞(osteocyte)及蝕骨細胞(osteoclast)三種基本的細胞。骨母細胞來源於未
分化的多潛能幹細胞（pluripotent mesenchymal stem cell），即骨髓基質幹細胞（bone marrow stromal stem 
cell）或結締組織間葉幹細胞(connective tissue mesenchymal stem cell)。這些前驅細胞(precursors)只要有
適當的刺激，再經由增生及分化作用而成為前骨母細胞(preosteoblast)，此時的細胞就會分化為成熟骨
母細胞(mature osteoblast)。骨母細胞最早期的標記為鹼性磷酸酵素(alkaline phosphatase, ALP)與骨骼涎
蛋白(bone sailoprotein，BSP)，較晚期則是 osteopontin與骨鈣素(osteocalcin)，而在骨母細胞整個分化
過程中均可發現第一型膠原蛋白之產生(type I collagen) [Rosen and Bouxsein, 2006]。此外，進行硬骨組
織重建所需的細胞來源除直接取自體、異體或異種之組織細胞外，人體內之幹細胞因具有不斷自我更
新之增殖能力及能夠分化成某些特定的細胞型態，所以目前許多學者正積極的試圖了解由幹細胞分化
成為許多特定組織細胞的機制，從而在體外調控將其誘導分化成為特定的器官或是組織的細胞。其
中，骨髓間葉幹細胞可於體外培養數個世代(passages)並分化成肢芽中胚層(limb-bud mesodermal)之細
胞形態，其中包含有骨母細胞(osteoblasts)、軟骨母細胞(chondroblasts)、脂肪細胞(adipocytes)、纖維母
細胞(fibroblasts)及 skeletal myoblasts等，根據目前研究中，骨髓中的間葉幹細胞已經被證實具有發展
分化成軟/硬骨前驅細胞(osteochondral progenitor)之能力，長久以來一直被視為骨組織生長、重塑及缺
陷修補的重要來源，也廣泛地被應用於骨質新生細胞分化的研究上[Li et al., 2005]。 
 
                                                                   7
達 28.9 %、絲氨酸(serine)達 10.9 %、酪氨酸(tyrosine)達 9.46 %。絲膠可以藉由脫膠(egumming )的步驟
幾乎完全除去。蠶紡絲的過程改變了其二級結構，由 Silk I(在腺體的儲存狀態)轉變成 SilkⅡ，因此增
強了 β-晶性特徵。在體外，有不同的方法去讓 Silk I轉變成 SilkⅡ，最有效的方法即是醇類的處理，
而應用在後面實驗的執行中，這些處理要讓蠶絲蛋白薄膜增進不溶水性[Kim et al., 2005]。 
   絲在早期的臨床應用多為縫線的使用，近期也有體內外的生物支架研究。就如同其他的生醫材料，
一開始為平面薄膜的研究，Minoura等人發現由 B. mori家蠶以及 Antheraea pernyi野生種的原態蠶絲
蛋白(直接由蠶線體中取出)製成的薄膜與膠原蛋白薄膜比較下，確實達成了支持鼠類 L-929 細胞貼附
散佈以及增殖的情形。而 Inouye 和 Gotoh等學者稍後也發現了以 9莫耳濃度的溴化鋰溶液重製的蠶
絲蛋白(regenerated silk)薄膜也能支持人類及動物細胞株的貼附及生長。作者歸因於蠶絲蛋白序列中 C
端的非重複性序列為帶有正電性胺基酸的親水性區域，而哺乳類細胞表面多帶負電，造成正負電相吸
的現象，因而促進貼附。而也有學者發現在野生種 Antheraea pernyi 蠶絲蛋白薄膜會較家蠶的蠶絲蛋
白薄膜有更強的細胞貼附性，原因在於野生種有三胜肽 RGD序列，是 integrin介導細胞貼附的辨認位，
是家蠶所沒有的。蠶絲蛋白分解的研究方面，有學者發現，脫膠後蠶絲於含蛋白質分解酵素磷酸鹽緩
衝溶液(otease XIV)至少於 77天後才會開始明顯的分解，說明了蠶絲蛋百具生物可分解的特性以及其
延長的分解時間[Horan et al., 2005] 。 
    蠶絲由於高生物相容性、緩慢降解速率、及絕佳機械強度，被認為是最具取代膠原蛋白於組織工
程應用之天然蛋白質材料[Dal Pra et al., 2005; Horan et al., 2005]。蠶絲蛋白(silk fibroin)長久以來在生醫
用途上均做為縫線材料，做為組織工程生醫材料，具有高氧氣與水分通透、促進細胞生長與貼附、低
免疫反應、體內緩慢降解、及高伸張強度等特性[Gotoh et al., 2002; Altman et al., 2003]。近來於骨組織
工程研究上，蠶絲蛋白支架亦發現能使骨細胞礦化，與表現 alkaline phosphatase活性(骨母細胞分化指
標之一)[ Meinel et al., 2004; Uebersax et al., 2006] ，故在骨組織工程應用上，蠶絲蛋白是適合的材料。
蠶絲蛋白於硬骨組織工程上為運用相當廣乏的生物高分子；研究發現蠶絲蛋白有著相當好的機械性
質、生物相容性及較慢的生物降解特性[Altman et al., 2003]，此外，經由電紡織法製備出的蠶絲蛋白奈
米纖維膜可成功的培養軟骨細胞(chondrocytes)、骨母細胞(osteoblast)及人類間葉幹細胞，且也有文獻
提出蠶絲蛋白奈米纖維膜可促進細胞的貼附及生長[Jin et al., 2004; Baek et al., 2008]。先前研究使用蠶
絲蛋白與 BMP-2混合製備成奈米纖維膜，培養人類間葉幹細胞細胞，發現較蠶絲蛋白與氫氧基磷灰
石複合奈米纖維膜，具更高之鈣離子分泌與骨母細胞分化基因表現能力[Li et al., 2005; Li et al., 2006]。
此外，於 2005年 Kim等人將製備好之蠶絲蛋白奈米纖維膜進行紐西蘭白兔活體試驗，其在兔子頭蓋
骨上製造一個直徑 8 mm骨缺損後，再將其奈米纖維膜支架植入骨缺損部位。其植入 12週後，經由組
織切片染色發現先前骨缺損的部位已成功之達成修復[Kim et al., 2005]。 
 
 
                                                                   9
代膠原蛋白之最受重視之天然高分子材料之一[Yamaguchi et al. 2001; Muzzarelli & Muzzarelli 2002; Hu 
et al. 2004)]。幾丁聚糖的來源皆來自天然的生物體，本身並無毒性且具良好的生物相容性與降解性，
所以在食品的添加、化妝品保濕、減肥產品的應用、生醫材料等方面上都具有極大的潛力[Elcin et al., 
1998]。先前實驗結果證實，幾丁聚醣雖不利於間葉幹細胞之生長，但會促進間葉幹細胞之骨母分化，
證實了幾丁聚醣具有骨傳導性(osteoconductive)之特性[Moreau and Xu, 2009]。 
 
研究方法 
 
一、蠶絲蛋白/幾丁聚醣複合性奈米纖維膜之製備 
    先將蠶絲蛋白(Bombyx mori)加以純化，純化方式為先置入 0.5 %(w/v) 碳酸氫鈉水溶液於 70℃，
以進行脫去絲膠的步驟 30 分鐘，後再以二次水清洗，重複脫膠兩次，脫膠之蠶絲再以真空烘箱烘乾
後，置入氯化鈣/乙醇/二次水(莫耳分率為 1:2:8)之溶解溶液中，於 65℃下放置 6小時，再將得到之蠶
絲蛋白溶液抽氣過濾，以濾除大分子雜質，後再以五分升二次水進行透析(MWCO 50,000)，一天換水
兩次其透析五天，透析後得到之蠶絲蛋白溶液以冷凍乾燥處理，即可得到蠶絲蛋白海綿團塊，而後保
存於 4C冰箱中備用。將蠶絲蛋白團塊、幾丁聚醣 (MW: 150000, degree of deacetylation= 98%, Fluka)
與蠶絲蛋白/幾丁聚醣(50/50, w/w)分別個自溶解於三氟醋酸/二氯甲烷(7:3, w/w)溶液中，其濃度分別為
12.5、8、10 wt.%。溶解後之溶液分別將針筒吸取，裝置在後端微量蠕動馬達(syringe pump)上，其所
用之針頭為 22 規格(gauge)，而於收集器上貼覆鋁箔紙，以收集電紡纖維絲；其電紡參數為：電壓：
18 kV、流速：0.5 ml/hr、工作距離：12 cm。而後所製備出之奈米纖維膜再以 7% (v/v) 氨水與 75% (v/v) 
乙醇混合溶液中於室溫進行 30 分鐘之改質，其目的分別為去除殘餘的三氟醋酸與增強蠶絲蛋白纖維
膜的溶水性。 
 
二、蠶絲蛋白/幾丁聚醣複合性奈米纖維膜之物理特性分析 
1. 掃描式電子顯微鏡之分析(SEM) 
製備出之薄膜裁剪為適當大小(約長 0.5 cm，寬 0.5 cm)固定於貼有導電碳膠之載台，以離子濺度
機設定時間為 60 秒，電流為 20 mA 後開始鍍金。將鍍金過後之載體放入掃描式電子顯微鏡(SEM)腔
體中並抽真空，即可利用電腦擷取掃描式電子顯微鏡高倍率之圖像，以觀察觀察奈米纖維之形態，接
著再以影像分析軟體量測 SEM圖像水平位置上 10條纖維直徑，同一樣品重複四張不同位置之 SEM，
並將全部平均得其平均直徑與誤差值(standard error)。 
 
2. 傅立葉轉紅外線光譜儀分析(FT-IR) 
使用傅立葉轉換紅外線光譜儀測定薄膜之分子鍵結。剪裁適當大小之複合性薄膜利用墊片夾住，
                                                                   11
值。 
 
3. 骨母細胞 calcium染色及定量 
將已培養之 24-well細胞培養盤內的培養基移除後，再加入的 PBS buffer沖洗兩次後，利用 2.5%
的 glutaraldehyde溶液(溶於 0.1 M phosphate buffer中)進行 2 hr的固定化反應。接著以下列方法進行染
色: 
    Calcium stain: 將 2 g的 Alizarin Red S 溶於 100 ml的 DDI水中，混合均勻後，以 10%的 ammonium 
hydroxide調整 pH值至 4.1~4.3，calcium染劑即配製完成。取 1 ml之染劑加入 well中，反應時間為 1 
hr、室溫，再以 DDI 水清洗直到水中無多餘染劑顏色；calcium 的染色結果為紅褐色。最後再以 10%
之 cetylpyridinium chloride (CPC)將紅褐色溶解後，以 ELISA reader於 540 nm波長下讀取吸光值。 
 
4. SEM樣品前處理 
將已培養之 24-well細胞培養盤內的培養基移除後，再加入的 PBS buffer沖洗兩次後，利用 2.5%
的 glutaraldehyde溶液(溶於 0.1 M phosphate buffer中)進行 2 hr的固定化反應。待固定時間完成後，以
PBS buffer清洗 3次(20 min/次)，再將細胞/支架置於 1% 鋨酸( in 0.1 M phosphate )中，固定 2小時後，
再用二次水清洗 3次(20 min/次)。接著，再以濃度為 50 %、70 %、80 %、90 %、95 %的酒精將水膠做
梯度脫水處理(20 min/次)，最後再以 100 %的絕對酒精浸泡 3次(30 min/次，最後一次 overnight)。將已
脫水處理後的細胞/支架載體置入臨界點乾燥機(critical point dryer，CPD)進行乾燥步驟(8次，10 min/
次)，而後立即鍍金並做 SEM 觀察。其再以能量散射光譜分析儀(EDS)作元素分析，以分析細胞礦化
後鈣與磷之元素表現。 
 
5. 螢光染色法進行細胞存活率/細胞毒性(Live/Dead)之測試 
先製備螢光染劑: 取 5 μl的 2 mM EthD-1溶液(EthD-1之激發光與放射光分別為 528 nm與 617 nm)
與 3 μl的 4 mM calcein AM 溶液(calcein AM之激發光與放射光分別為 494 nm與 517 nm)，同時加入
10 ml之 PBS緩衝溶液中，混合均勻，螢光染劑配製完成。接著將特定培養週期後之細胞/支架複合物
直接置於載玻片上，並進行螢光染色實驗，在避光的環境下，取 300 μl之螢光試劑加在細胞/支架上，
靜置數分鐘後，利用雷射共軛焦顯微鏡觀察細胞之存活率與細胞毒性。若是進行平面培養，則螢光染
劑可直接加入，靜置數分鐘後，利用螢光顯微鏡來觀察即可。 
 
6. Collagen type I、ALP、Osteocalcin與 Osteopontin mRNA表現分析 
6.1 細胞 RNA之萃取 
將已培養之 24-well細胞培養盤內的培養基移除後，再加入的 PBS buffer沖洗兩次，接著添加 1 ml 
                                                                   13
五、裸鼠活體內試驗 
1. 實驗動物 
所有實驗之裸鼠(nude mice)選擇條件如下：選擇 20-30g重(約 6-8週齡)之裸鼠，隨機選擇 4隻一
組。 
 
2. 體內細胞培養 
將人類間葉幹細胞植入奈米纖維膜，其分化 14 天後，再將蠶絲蛋白/幾丁聚醣複合性奈米纖維膜
植入裸鼠背部之皮下組織，經特定天數後取出奈米纖維膜，再以 HE 染色其分析細胞分佈與型態，最
後再以免疫組織化學染色法分析其特定蛋白之分布情形。 
 
3. 免疫組織化學法(Immunohistochemistry) 
3.1 玻片之前處理 
以 75%酒精擦拭玻片後，取 25 mL之 poly-lysine均勻塗於玻片上，在置於玻片烘乾機上烘乾備用。 
 
3.2 組織之石蠟包埋及切片 
將組織浸漬於 10%三聚甲醛溶液(formaldehyde)，於室溫下靜置 6~12小時，再利用不同濃度之酒
精(70、80、90、95及 100%)於室溫下輕微震盪 2小時，以進行脫水反應，續以二甲苯(xylene)輕微震
盪 2小時，另經 3次 60%之石蠟(parapalst)脫脂 12小時後進行石蠟之包埋。將包埋好之組織置於冰上，
待石蠟凝固變硬後，修飾片匣(cassette)多餘之石蠟，後利用旋轉式切片機將包埋好之組織進行連續切
片(厚度約為 5 m)，切下後置於蠟浴槽中進行展片，再將展片後之組織以玻片呈接，並置於玻片烘乾
機上烘乾。 
 
3.3 免疫組織化學分析 
將上述烘乾之切片置於二甲苯中脫蠟後，經由不同濃度之酒精(100、90、80 及 70)進行水和
(rehydration)，水和後之組織以 PBS進行清洗各兩次。將洗清後之組織置於 95 C之 10 mM檸檬酸鹽
溶液（citrate acid buffer pH 6.0）中 30分鐘，再於室溫下冷卻，分別以 5% NP-40及 3% H2O2之甲醇溶
液中浸泡 15分鐘，以去除過氧化酶(peroxidase)之活性，再經由 PBS清洗組織三次後，分別添加適當
稀當倍數(視抗體效價而定)之抗體，於 4C反應 12-16小時，後以 PBS清洗三次每次 5分鐘。隨即加
入 100 L之二級抗體，於室溫下反應 30分鐘，待以 PBS清洗三次每次 5分鐘，再加入 100 μL之受
質(3,3’-diaminobezidine tetrahydrochloride; DAB, Zymed Laboratories)，於室溫下反應約 5~10分鐘，而
後以 PBS 清洗。另以蘇木紫(hematoxylin)進行對比染色(counterstain)後固定封片。影像以光學顯微鏡
配合數位相機拍攝之。 
 
                                                                   15
I)、1519 cm-1 (amide II)以及 amide III 之特徵峰 1241 cm-1，其證明蠶絲蛋白經由乙醇改質後，結構已
從 random coil改變為 β-sheet，以增強蠶絲蛋白纖維膜的溶水性。而幾丁聚醣/蠶絲蛋白(50:50)之奈米
纖維膜經改質後，幾丁聚醣及蠶絲蛋白之特徵峰皆鍵結震盪及轉移分別位於 1626 cm-1及 1537 cm-1，
其上述之分析結果，都與先前文獻結果相同一致[Chen et al., 2012]，亦證明本研究製備出的奈米纖維
膜確實含有幾丁聚醣與蠶絲蛋白。 
                  Wavenumber (cm-1)
80010001200140016001800
Tr
an
sm
itt
an
ce
a
b
c
1637
1548
1626
1537
1617
1519
1241
 
圖二、幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維膜之 FTIR分析圖。 
 
1.3 X光結晶繞射分析 (XRD) 
奈米纖維膜以 X-ray 繞射分析，結果如圖三所示。其分析結果顯示幾丁聚醣之晶格波峰為 11.5°
及 20.1°，蠶絲蛋白之 random coil波峰為 20.5°，β-sheet則為 24.5°﹔而幾丁聚醣/蠶絲蛋白(50:50)之複
合性奈米纖維膜皆有上述之波鋒。此 XRD分析之結果，都與先前文獻結果相同一致[Chen et al., 2012]，
亦證明本研究製備出的奈米纖維膜確實含有幾丁聚醣與蠶絲蛋白。 
                  2-Theta
5 10 15 20 25 30 35
In
te
ns
ity
a
b
c
20.1
11.5
20.5 24.5
 
圖三、幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維膜之 XRD分析圖。 
                                                                   17
Days of differentiation
Day 0 Day 3 Day 7 Day 14 Day 21 Day 28
A
LP
 a
ss
ay
 (O
D
40
5)
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
Chitosan 
Chitosan:Silk (50:50) 
Silk 
TCPS 
*
*
*
*
 
圖五、人類間葉幹細胞於幾丁聚醣、幾丁聚醣/蠶絲蛋白(50:50)及蠶絲蛋白及奈米纖維膜下，ALP活性
分析 (n=5)。*p < 0.05。 
 
2.3 奈米纖維膜上間葉幹細胞分化骨母細胞之細胞型態與能量分散光譜儀(EDS)之分析 
2.3.1 幹細胞分化骨母細胞於奈米纖維膜上之細胞型態 
    本實驗將幹細胞植入於幾丁聚醣、蠶絲蛋白/幾丁聚醣 (50/50)、及蠶絲蛋白奈米纖維膜中，並以
SEM分析於不同誘導培養天數(7、14及 21天)後之細胞型態，如圖六、七、八所示。其結果顯示於幾
丁聚醣與蠶絲蛋白/幾丁聚醣 (50/50)奈米纖維膜上，細胞具有很明顯的礦化堆積，且隨著天數的增加，
礦化堆積的越多；而在蠶絲蛋白奈米纖維膜上，細胞之礦化現象明顯少了許多。除此之外，也從 SEM
分析圖上發現，細胞於蠶絲蛋白奈米纖維膜上分泌較多的細胞外基質(extracellular matrix, ECM)，反
之，幾丁聚醣奈米纖維膜上，細胞則較少分泌 ECM，以聚集之型態較多；證實蠶絲蛋白可促進細胞的
貼附及生長，而幾丁聚醣則可幫助骨母細胞之分化。 
   
圖六、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維膜 
7天之 SEM圖。 
a b c 
                                                                   19
   
 
圖九、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維膜
7天之 EDS分析圖。 
   
圖十、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維膜
14天之 EDS分析圖。 
   
圖十一、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維
膜 21天之 EDS圖。 
 
 
 
a b c 
a b c 
a b c 
                                                                   21
   
圖十一、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維
膜 3天之 ALP染色圖。 
   
圖十二、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維
膜 7天之 ALP染色圖。 
   
圖十三、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維
膜 14天之 ALP染色圖。 
 
3.2 骨母細胞鈣染色及定量 
    幹細胞分化骨母細胞於後期時，骨母細胞會有鈣的堆積，因此本實驗也以鈣染色及定量分析，以
觀察幹細胞之分化情形，其染色結果為紅褐色，結果如圖十四、十五、十六所示。結果顯示幾丁聚醣
a b c 
a b c 
a b c 
                                                                   23
            Days of differentiation
Day 14 Day 21 Day 28
Ab
so
rb
an
ce
 (O
D
54
0)
0
1
2
3
4
5
6 Chitosan 
Chitosan:Silk (50:50) 
Silk 
*
*
*
 
圖十七、人類間葉幹細胞於幾丁聚醣、幾丁聚醣/蠶絲蛋白(50:50)及蠶絲蛋白奈米纖維膜下，細胞分化
鈣定量(OD540)之分析 (n=5)。*p < 0.05。 
 
3.3 骨母細胞 Von Kossa染色 
    Von Kossa 染色可將骨母細胞礦物質化結節中的磷酸鈣染成暗褐色磷酸銀沉澱，因此本實驗也以
此染色法，以觀察幹細胞之分化情形，結果如圖十八所示。其結果顯示細胞分化 28 天後，幾丁聚醣
與蠶絲蛋白/幾丁聚醣 (50/50)奈米纖維膜上，礦化之染色明顯比蠶絲蛋白奈米纖維膜多了許多。 
   
圖十八、人類間葉幹細胞培養於幾丁聚醣(a)、幾丁聚醣/蠶絲蛋白(50:50) (b)、及蠶絲蛋白(c)奈米纖維
膜 28天之 Von Kossa染色圖。 
 
3.4 螢光染色法進行細胞存活率/細胞毒性(Live/Dead)之測試 
    利用螢光染色法(Live/Dead)分析幹細胞於幾丁聚醣、蠶絲蛋白/幾丁聚醣 (50/50)、及蠶絲蛋白奈
米纖維膜中細胞之形態，如圖十九所示。其結果顯示細胞培養三天後，幾丁聚醣與蠶絲蛋白奈米纖維
a b c 
                                                                   25
  
           
                     
 
 
 
 
 
           
 
 
 
 
 
 
 
圖二十、人類間葉幹細胞於幾丁聚醣、幾丁聚醣/蠶絲蛋白(50:50)、及蠶絲蛋白奈米纖維膜下，(a) 
collagen type I、(b) ALP 、(c) OCN、 (d) OP 之 mRNA表現分析 (n=5)。*p < 0.05。 
 
5. 裸鼠活體內試驗 
綜合以上細胞與複合性奈米纖維膜生物相容性及分化分析實驗證實，本研究所使用之幾丁聚醣與
蠶絲蛋白對人類間葉幹細胞分化與生長似乎扮演不同角色；幾丁聚醣可幫助骨母細胞之分化，而蠶絲
蛋白可促使細胞的貼附及生長，然而本研究於硬骨組織工程之研究上，期望能製備出既能利於細胞的
貼附及生長外，也能促使細胞分化的生醫材料；因此，本研究選用幾丁聚醣/蠶絲蛋白(50:50)奈米纖維
膜以進行活體內(in vivo)試驗。將人類間葉幹細胞種入奈米纖維膜，分化培養 14天後，再將蠶絲蛋白/
幾丁聚醣 (50:50)奈米纖維膜/細胞複合物植入裸鼠背部之皮下組織，經 28 及 56 天數後取出奈米纖維
膜，再以 H&E染色分析細胞分佈與型態，以及骨母細胞鈣與 Von Kossa染色分析礦化情形，最後再以
免疫組織化學染色法分析其第一型膠原蛋白及骨鈣素之分布情形。 
Days of differentiation
Day 14 Day 21
C
ol
la
ge
n 
ty
pe
 I 
/ G
AP
D
H
0
2
4
6
8
Chitosan 
Chitosan:Silk (50:50) 
Silk 
TCPS 
* *
Days of differentiation
Day 14 Day 21
AL
P 
/ G
AP
D
H
0
1
2
3
4
5
6
Chitosan 
Chitosan:Silk (50:50) 
Silk 
TCPS 
*
Days of differentiation
Day 14 Day 21
O
C
N
 / 
G
A
P
D
H
0.0
0.5
1.0
1.5
2.0
2.5 Chitosan 
Chitosan:Silk (50:50) 
Silk 
TCPS 
*
*
Days of differentiation
Day 14 Day 21
O
PN
 / 
G
A
PD
H
0
1
2
3
4
5
6
Chitosan 
Chitosan:Silk (50:50) 
Silk 
TCPS 
*
*
                                                                   27
 
      
圖二十三、人類間葉幹細胞植入蠶絲蛋白/幾丁聚醣複合性(50:50)奈米纖維膜，分化14天後，再將奈米
纖維膜植入裸鼠背部之皮下組織之OCN免疫染色圖。(a) 28天，(b) 56天。 
 
      
圖二十四、人類間葉幹細胞植入蠶絲蛋白/幾丁聚醣複合性(50:50)奈米纖維膜，分化14天後，再將奈米
纖維膜植入裸鼠背部之皮下組織之鈣染色圖。(a) 28天，(b) 56天。 
a 
a b
b
                                                                   29
3. H. S. Baek, Y. H. Park, C. S. Ki, J. C. Park, D. K. Rah, “Enhanced chondrogenic responses of articular 
chondrocytes onto porous silk fibroin scaffolds treated with microwave-induced argon plasma”, Surface 
and Coatings Technology, 202, 5794-5797 (2008). 
4. N. Bhattarai, D. Edmondson, O. Veiseh, F. A. Matsen, M. Zhang, “Electrospun chitosan-based 
nanofibers and their cellular compatibility”, Biomaterials 26, 6176-6784 (2005). 
5. N. Bolgen, Y. Z. Menceloglu, K. Acatay, I. Vargel and E. Piskin, “In vitro and in vivo degradation of 
non-woven materials made of poly (ε- caprolactone) nanofibers prepared by electrospinning under 
different conditions”,  J. Biomater. Sci. Polymer Edn, 16, 1537-1555 (2005). 
6. J.P. Chen, G..Y. Chang, J.K. Chen, “Electrospun collagen/chitosan nanofibrous membrane as wound 
dressing”, Colloids and Surfaces A: Physicochem. Eng. Aspects, 313-314, 183-188 (2008). 
7. J.P. Chen, S. H. Chen, G. J. Lai, “Preparation and characterization of biomimetic silk fibroin/chitosan 
composite nanofibers by electrospinning for osteoblast culture, Nanoscale Research Letters 7, 170-181 
(2012). 
8. I. Dal Pra, G. Freddi, J. Minic et al., “De novo engineering of reticular connective tissue in vivo by 
silk fibroin nonwoven materials”, Biomaterials 26, 1987–99 (2005). 
9. M. Doi, A. Nagano, and Y. Nakamura, “Genome-wide screening by cDNA microarray of genes 
associated with matrix mineralization by human mesenchymal stem cells in vitro”, Biochem. Biophys. 
Res. Commum, 290, 381-390, (2002). 
10. B. Duan, C. Dong G, X. Yuan, “Electrospinning of chitosan solutions in acetic acid with poly(ethylene 
oxide)”, J. Biomater. Sci. Polymer Edn. 15, 797–811 (2004). 
11. Y. M. Elcin, V. Dixit, G. Gitnick, ”Hepatocyte attachment on biodegradable modified chitosan 
membrabes: in vitro evaluation for the development of liver organoids.artif organs”, Artifical Organs, 22, 
837-846 (1998). 
12. A. Formhals, US patent, 1,975,504 (1934). 
13. A. Formhals, US patent, 2,160,962 (1939). 
14. A. Formhals, US patent, 2,187,306 (1940). 
15. X. Geng, O.H. Kwon, J. Jang, „Electrospinning of chitosan dissolved in concentrated acetic acid 
solution”, Biomaterials 26, 5427–5432 (2005). 
16. Y. Gotoh, N. Minoura, T. Miyashita, “Preparation and characterization of conjugates of silk fibroin 
and chito-oligosaccharides”, Colloid Polym. Sci. 280, 562-568 (2002). 
17. R. L. Horan, K. Antle, A. L. Collette et al., “ In vitro degradation of silk fibroin”, Biomaterials 26, 
3385–93 (2005). 
18. Q. Hu, B. Li, M. Wang, J. Shen, “Preparation and characterization of biodegradable 
                                                                   31
33. Q. P. Pham, U. Sharma, A. G. Mikos, “Electrospinning of Polymeric Nanofibers for Tissue Engineering 
Applications: A Review”, Tissue Engineering, 12, 1197-1211 (2006). 
34. C. J. Rosen, M. L. Bouxsein, “Mechanisms of Disease: is osteoporosis the obesity of bone?”, Nature 
Clinical Practice Rheumatology, 2, 35-43 (2006). 
35. W. J. Shih, Y. F. Chen, M. C. Wang, M. H. Hon, “Crystal growth and morphology of the nano-sized 
hydroxyapatite powders synthesized from CaHPO4．2H2O and CaCO3 by hydrolysis method”, Journal of 
Crystal Growth, 270, 211–218 (2004). 
36. A. Subramanian, D. Vu, G. F. Larsen, H.Y. Lin, “Preparation and evalution of the electrospun 
chitosan/PEO fiber for potential application in cartilage tissue enginerring”, J.Biomater. Sci.Polymer 
Edn. 16, 861–873 (2005). 
37. G. I. Taylor, “Electrically driven jets”, Proc. Toy. Soc. London, A313, 453-475 (1969). 
38. V. Thomas, S. Jagani, K. Johnson, M. V. Jose et al., “Electrospun bioactive nanocomposite scaffolds of 
polycaprolactone and nanohydroxyapatite for bone tissue engineering”, Journal of Nanoscience and 
Nanotechnology, 6, 487-493 (2006). 
39. L. Uebersax, H. Hagenmuller, S. Hofmann et al., “Effects of scaffold design on bone morphology 
in-vitro”, Tissue Eng., 12, 3417-3429 (2006). 
40. J. R. Venugopal, A. T. C. S. Low, A. B. Kumar, S. Ramakrishna, “Nanobioengineered electrospun 
composite nanofibers and osteoblasts for bone regeneration”, Artificial Organs, 32, 388–397 (2008). 
41. Y. K. Wang, T. Yong, S. Ramakrishna, “Nanofibers and their influence on cells for tissue regeneration”, 
Aust. J. Chem., 58, 704-712 (2005). 
42. I. Yamaguchi, K. Tokuchi, H. Fukuzaki et al., “Preparation and microstructure analysis of 
chitosan/hydroxyapatite nanocomposites”, J. Biomed. Mater. Res., 55, 20–27 (2001). 
characteristics of the NF but also from its composition,
such as combining suitable ECM components like pro-
teins and polysaccharides to fabricate composite NFs [5].
Silk emitted by the silkworm consists of two main
proteins, sericin and silk fibroin [SF], fibroin being the
structural center of the silk and sericin being the sticky
material surrounding it. The SF protein mainly consists
of the recurrent amino acid sequence (Gly-Ser-Gly-Ala-
Gly-Ala)n. Among the biodegradable and biocompatible
polymers, SF was extensively studied as one of the can-
didate materials for biomedical applications because it
has several distinctive biological properties including
good biocompatibility, biodegradability, and minimal
inflammatory reaction [6]. Various methods have been
proposed to process SF into different kinds of scaffolds
such as films, gels, sponges, and non-woven mats for
biomedical applications [7], including NFs by electro-
spinning [8,9]. The SF NFs have been used to culture
with chondrocytes, osteoblasts, and mesenchymal stem
cells and reported to enhance cell proliferation and
attachment [10-12]. Chitosan [CS] is a GAG-like linear
polysaccharide composed of glucosamine and N-acetyl
glucosamine linked in a b(1®4) manner and is deacety-
lated from chitin, the second most abundant natural
biopolymer in the world [13]. This natural biomaterial is
found in the shells of crustaceans and is with antibacter-
ial, biocompatible, and biodegradable properties [14]. It
is widely used for biomedical applications, such as
wound dressings, drug delivery carriers, and tissue engi-
neering scaffolds [15]. The CS NFs have also been pro-
duced by electrospinning [16].
Composite NFs are promising as tissue engineering
scaffolds by blending protein and polysaccharide in the
spinning solution. However, a well-designed processing
condition must be found beforehand to fabricate bead-
free nano-sized fibers from the blend spinning solution
during the electrospinning step. Previously, collagen/CS
NFs have been prepared and used as wound dressings
and tissue engineering scaffolds [17,18]. Both endothelial
cells and smooth muscle cells proliferated well on these
composite NFs. SF/chitin NFs were found to enhance
keratinocytes and fibroblasts attachment and spreading
[19]. SF/CS NFs have also been fabricated, but the maxi-
mum CS content in the composite can only reach 30 wt.
% [20]. Application of this composite scaffold for bone
tissue engineering applications will be promising as CS
is beneficial for osteogenic differentiation only if the CS
content can be raised.
In this study, electrospun SF/CS composite NFs cover-
ing the whole range of CS content from 0 to 100 wt.%
were successfully fabricated using a trifluoroacetic acid
[TFA]/dichloromethane [DCM] mixed solvent system.
To make the NFs suitable for bone tissue engineering
applications, a new chemical treatment method using
ethanol/ammonia was developed to completely remove
harmful TFA residues from the NFs and make the NFs
insoluble in culture medium. The chemically treated
NFs were shown to promote the proliferation and osteo-
genic differentiation of human fetal osteoblastic [hFOB]
cells by the action of the SF and CS component in the
NFs, respectively.
Methods
Preparation of SF/CS blend solution
Bombyx mori silk fibers were treated twice with 0.5%
(w/w) NaHCO3 solution at 70°C for 30 min and then
rinsed with 70°C distilled water to remove sericin.
Degummed silk was dissolved in a mix solvent system
of CaCl2/CH3CH2OH/H2O (mole ratio, 1:2:8) at 70°C
for 6 h and filtered to get a SF solution. After dialysis in
a cellulose dialysis tubing (MWCO = 50,000) against
distilled water for 5 days with water change every 12 h,
the SF solution was lyophilized to obtain regenerated SF
sponges. Chitosan (MW = 1 × 105, degree of deacetyla-
tion = 98%) was purchased from Fluka (Buchs, Switzer-
land). CS and SF solutions were prepared in a mixed
solvent system of TFA/DCM (weight ratio = 7:3) at con-
centrations of 8 and 12.5 wt.%, respectively. CS/SF blend
solutions with different SF/CS weight ratio (75:25, 50:50,
and 25:75) were prepared in the same solvent system at
12, 10, and 9 wt.% (combined weight of CS and SF),
respectively.
Preparation of SF/CS nanofibers by electrospinning and
chemical treatment
The system for electrospinning includes a glass syringe,
a 22-gauge stainless-steel needle, a syringe pump (KD
Scientific Co., Holliston, MA, USA), a high-voltage
power supply (Glassman, High Bridge, NJ, USA), and an
aluminum foil as the collector [21]. The distance
between the needle tip and the collector was 16 cm.
The syringe was mounted on the syringe pump, and
spinning solution was drawn horizontally from the nee-
dle tip with an electrostatic force generated from the
high voltage applied between the tip and the grounded
collector. The applied voltage and flow rate were con-
trolled at 18 kV and 0.3 ml/h, respectively. For chemical
treatment, the SF/CS composite NFs were neutralized,
crystallized, and insolubilized by immersing in 7% (v/v)
ammonia solution/75% (v/v) ethanol aqueous solution
for 30 min at room temperature.
Measurement and characterization
The morphology of the NFs was observed by a scanning
electron microscope [SEM] (Hitachi S3000N, Hitachi,
Ltd., Chiyoda, Tokyo, Japan). The diameters were calcu-
lated by measuring at least 100 fibers from 10 images at
random using ImageJ. Chemical analysis was carried out
Chen et al. Nanoscale Research Letters 2012, 7:170
http://www.nanoscalereslett.com/content/7/1/170
Page 2 of 11
distribution, and the average fiber diameter was calcu-
lated from Figure 1 and summarized in Table 1. The
average fiber diameter ranges from 215 to 478 nm. The
pore sizes of SF/CS membranes determined by capillary
flow porometry are also included in Table 1 and range
from 0.52 to 1.23 μm. To distinguish and visualize indi-
vidual biopolymer component in the NF, FITC-CS and
Rd-SF were used to prepare the electrospun 50% SF/
50% CS NFs under the same fabrication conditions. The
confocal microscopy images in Figure 2 confirm that the
NF is composed of SF and CS, and the distribution of
each constituent in the NF is uniform.
As TFA will form salts with protonated amino groups
of CS or SF, the NF could dissolve in aqueous solutions,
which limit its use in cell culture and as tissue engineer-
ing scaffold. Residual TFA in the NF is also highly toxic
towards cells and may lead to cell death if not removed
completely. Chemical treatment of pristine NFs was
therefore necessary. In this study, we have developed a
new chemical treatment method using aqueous solution
Figure 1 SEM micrographs (A to E) and histograms of fiber diameters (F to J). Electrospun SF/CS nanofibers with different CS contents: (A),
(F) 100% CS; (B), (G) 75% CS; (C), (H) 50% CS; (D), (I) 25% CS; and (E), (J) 0% CS. Bar = 10 μm.
Chen et al. Nanoscale Research Letters 2012, 7:170
http://www.nanoscalereslett.com/content/7/1/170
Page 4 of 11
peaks of treated CS NFs are stretching of C = O and
NH2 around 1,637 and 1,548 cm
-1. However, the three
transmittance peaks associated with TFA salts at 720,
796, and 836 cm-1 disappeared after alkaline treatment
(Figure 4B, curve b), which could be also observed from
Figures 4C, D[22,23]. The characteristic transmittance
peaks of pristine SF NFs are 1,650 (amide I) and 1,535
cm-1 (amide II), which could be attributed to the ran-
dom coil protein conformation. These peaks shift to
1,617 and 1,519 cm-1 after ethanol treatment, indicating
conformation structure change from random coil to b-
sheet (Figure 4C) [26,27]. The characteristic transmit-
tance peaks of pristine 50% SF/50% CS NFs show both
SF and CS characteristic peaks (Figure 4D). Peak shifts
at 1,670 and 1,539 cm-1 again confirm the conformation
change of SF in the composite NF after chemical treat-
ment, and the C = O and NH2 stretching bands of CS
merge with SF bands in the composite [28].
Two decomposition peak temperatures are observed
for pristine SF/CS NFs in contrast to only one for trea-
ted NFs from TG (Figure 5A) and differential thermo-
gravimetry [DTG] (Figure 5B) analysis [28,29]. The first
peak corresponds to the decomposition of the salt NH3
+-CF3COO
- while the second peak is due to the decom-
position of SF and CS. After chemical treatment, the
peak temperature due to salts formed from TFA and
protonated amines at 235°C disappeared, and only the
second peak at approximately 290°C could be observed,
reconfirming the complete removal of TFA by binding
with ammonium ions during the chemical treatment
process [24].
DSC analysis reveals unique features for pristine (Fig-
ure 5C) and treated (Figure 5D) NFs of different CS
contents. In a recent study, a strong exothermic peak at
305°C and a strong endothermic peak at 280°C were
reported for pure CS and SF, respectively [28,29]. Com-
pared with DTG, DSC analysis shows that only the NH3
+-CF3COO
- salt in CS leads to a new peak with the dis-
appearance of the exothermic peak at 305°C for CS and
appearance of a new endothermic peak at 222°C (Figure
5C). For pristine SF/CS composite NFs, two endother-
mic peaks due to SF and TFA-CS appear (Figure 5C).
After adding ammonia, the endothermic peak of TFA-
CS at 222°C changed back to the strong CS exothermic
peak at 298°C by completely removing TFA from NFs
with ammonium ions (Figure 5D). Also, the strong
endothermic peak of SF located at 278°C shifts to a
higher temperature at 282°C after the protein structure
being transformed into the b-sheet crystallization by
ethanol (Figure 5D) [30]. Interestingly, the DSC curve of
Figure 3 Scanning electron micrographs. Scanning electron micrographs of ammonia/ethanol treated SF/CS nanofibers with different CS
contents after being immersed in cell culture medium for 5, 14, and 54 days. Bar = 20 μm.
Chen et al. Nanoscale Research Letters 2012, 7:170
http://www.nanoscalereslett.com/content/7/1/170
Page 6 of 11
Culture of hFOB on SF/CS composite nanofibers
Figure 8 shows cell proliferation by MTS assays and cell
differentiation by ALP activities of hFOB. For relative
cell number, the number of viable cells at day 0 after
cell attachment for 4 h was taken as one for each
sample to compare the proliferation rate of cells in dif-
ferent NF scaffolds. The cell number and ALP activity
increased with culture time but show clear dependence
on the composition of the NF. The SF/CS NF with the
least amount of CS (25%) significantly promotes (p <
Figure 5 TGA, DTG, and DSC analyses. (A) TGA, (B) DTG, and (C, D) DSC analyses of pristine and chemically treated CS (a, a’), 50% SF/50% CS
(b, b’), and SF (c, c’) nanofibers. Curves a, b, and c are pristine nanofibers; curves a’, b’, and c’ are chemically treated nanofibers.
Figure 6 XPS survey scan spectra of 50% SF/50% CS
nanofibers’ surfaces before and after chemical treatment.
Figure 7 XRD patterns of treated SF/CS nanofibers with
different CS content.
Chen et al. Nanoscale Research Letters 2012, 7:170
http://www.nanoscalereslett.com/content/7/1/170
Page 8 of 11
cells in 25% SF/75% CS NFs can secrete the highest
amount of mineral particles from SEM observations.
Conclusions
Composite SF/CS NFs covering the whole range of CS
content can be prepared by electrospinning. Post-treat-
ment with ammonia/ethanol solution can totally elimi-
nate harmful TFA residue from the NF and render it
insoluble in cell culture medium and useful as tissue
engineering scaffold. hFOB cells could proliferate and
differentiate on the NFs. Each component in the compo-
site NF shows distinct effect on cell behavior, with SF
promoting cell proliferation and CS enhancing osteo-
genic differentiation. By choosing a suitable blend of
each component in the composite, 50% SF/50% CS NFs
will be a promising candidate scaffold for bone tissue
engineering.
Acknowledgements
Financial support from National Science Council of the Republic of China
and Chang Gung Memorial Hospital are highly appreciated.
Authors’ contributions
J-PC and S-HC designed the experiment. S-HC prepared and analyzed the
samples. S-HC and G-JL carried out cell culture experiments. All authors read
and approve the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 30 November 2011 Accepted: 6 March 2012
Published: 6 March 2012
Figure 9 Live/dead cell staining and SEM images of hFOB. (A to C) Live (green)/dead (red) cell staining of hFOB after 1 day cell culture (bar
= 100 μm) and SEM images of hFOB after 7 days (D to F) and 14 days (G to I) cell culture on SF/CS nanofibers with different CS contents (bar
= 20 μm).
Chen et al. Nanoscale Research Letters 2012, 7:170
http://www.nanoscalereslett.com/content/7/1/170
Page 10 of 11
參加美國化學會第242次年會 
242rd American Chemical Society National Meeting 
會議報告 
 
一、參加會議經過 
美國化學會第242次年會於2011年8月28日至9月1日於美國丹佛舉行。美國化學會每年
於春季及秋季各舉辦一次年會，此次年會為秋季舉行，為第242次會議，堪稱在化學領域
最盛大的會議。本次共發表超過7500篇論文，本次研討會所揭示之大會主題為Chemistry of 
Air, Space, and Water。Technical Program參與之分支(Division)包括有Agricultural & Food 
Chemistry, Agrochemicals, Analytical Chemistry, Biological Chemistry, Biochemical 
Technology, Business Development & Management, Carbohydrate Chemistry, Cellulose & 
Renewable Materials, of Chemistry & the Law, Chemical Health and Safety, Chemical 
Education, Chemical Information, Colloid & Surface Chemistry, Computers in Chemistry, 
Environmental Chemistry, Fluorine Chemistry, Fuel Chemistry, Industrial & Engineering 
Chemistry, Medicinal Chemistry, Nuclear Chemistry & Technology, Organic Chemistry, 
Petroleum Chemistry, Physical Chemistry, Polymeric Materials: Science & Engineering, 
Polymer Chemistry等，以下再細分超過500個sessions。另外在跨領域Multidisciplinary Areas
方面，於Nanomedicine, Materials, Nanotechnology, Sustainability in Energy, Sustainability in 
Water亦有連續議程。 
丹佛位於美中西部，有多家航空公司班機飛行，對國外參加者而言交通堪稱便捷，此
次會議主要目的仍在全世界集合化學領域研究之專家、學者與學生，就近年來之研究心得
互相交換意見，以期促進國際學術合作與技術交流。 
本次參加者大部份來自美國，其次為歐洲，亞洲地區，以日本、韓國為主，國內參加
人數算是還是遠少於前面各國參加者。由於每天口頭演講的時程是以並行方式進行，因此
remodeling in a rabbit femoral plug model＂，最值得討論。外傷後的骨缺損處的骨再生是骨
科及顏面外科常見的問題，傳統上常需要自體的骨移植以達到美觀的目的及功能回復，除
了自體骨移植以外其他選擇包括異種異體，同種異體骨移植，或是使用組織工程方式。組
織工程方式可避免免疫排斥或是感染某些傳染疾病的可能性。組織工程方式利用生物材料
為骨架，為了避免手術帶來更多的創傷，可注射性骨架搭載自體幹細胞並結合內視鏡手術
的方法在未來是值得發展的。可注射性骨架較傳統多孔性陶瓷骨架具有易塑型的優點，相
較於傳統手術也有不具侵入性的優勢，除此之外它可搭載骨生長因子進而促進骨生長，而
複合式可注射型骨架結合有機高分子與多孔性陶磁粉末尤其值得開發。Prof. Guelch研究中
利用組織工程的方法進行骨組織修復，為了提供骨細胞穩定、合適的生長空間及增加操作
實用性，結合天然的生醫材料PU合成可注射型的立體多孔性支架，另以具誘導骨生成能
力之多孔雙相磷酸鹽(氫氧基磷灰石/三鈣磷酸鹽)陶瓷粉末與支架混合，以增進細胞貼與分
化，及利用共包埋於水膠中之骨生長因子，將骨髓間葉幹細胞誘導分化成骨細胞，最後能
長成具功能性之骨組織，以達到修補受損骨組織的目的，並以兔子模式證實。 
相較於我國少數且年紀較長之參加者，本次會議有大量的日本與韓國研究生或年輕研
究人員參與，顯示於化學領域此兩個國家之研究潛力。因此衷心盼望國內年輕學子能積極
參加此種大型國際會議，以增加見聞並認識與結交年齡相似之研究者，以在未來有機會進
行國際交流與合作。 
 
三、攜回資料名稱及內容 
攜回大會議程與光碟論文摘要。美國化學會第243次年會預定2012年3月於San Diego
舉行，可由美國化學會網址投稿參加。 
Promega. The alkaline phosphatase (ALP) activity of hFOB 
was measured using the liquid substrate system for ELISA 
from Sigma and reported as the optical density at 405 nm 
(OD405). 
III. RESULTS AND DISCUSSION 
Fig. 1 showed the SEM micrographs of electrospun NFs. 
Beads-free NF could be produced for all ratios of SF/CS. The 
average fiber diameter for NFs with CS contents of 100%, 
75%, 50%, 25%, and 0% were 316.67 ± 109.19, 238.88 ± 
132.62, 446.93 ± 167.48, 215.21 ± 94.99, and 398.60 ± 183.80 
nm, respectively. To increase the biocompatibility and 
preserve the nanostructure of fiber when seeded with cells and 
cultured in medium, NFs are treated with ethanol/ammonia 
aqueous solution to remove residual TFA and to change SF 
protein conformation. SF could be insolubilized after 
treatment with alcohol when its conformation changed from 
silk I or random coil to silk II or β-sheet. Fig. 2 showed the 
SEM micrographs of NFs that was treated with 7% 
ammonia/75% ethanol solution, and then immersed in cell 
culture medium for 5 and 14 days. The SEM micrographs 
indicate that treatment of NFs with 7% ammonia/75% ethanol 
solution will render NFs insoluble by retaining the 
nanofibrous structure throughout the extended cell culture 
period.  
Fig. 3 showed the proliferation (relative cell number) and 
differentiation (alkaline phosphatase activity) of hFOBs 
cultured on different NFs and on TCPS (tissue culture 
polystyrene) controls. The cell numbers and osteocalcin 
production labels were significantly increased in accordance 
with culture period. The cells showed activity of ALP that was 
comparable to culture dishes, and were calcified similarly to 
culture dishes. The increase of cell number of hFOBs cultured 
on SF/CS NFs with 25% CS were significantly higher than 
those of other groups at day 28. In contrast, hFOBs cultured 
on SF/CS NFs with 75% CS gave the highest ALP activities 
among all groups after day 14. These results indicate that NFs 
can provide a more beneficial 3D environment for cell 
proliferation and differentiation compared to 2D TCPS. The 
results also indicated SF promoted osteoblasts proliferation 
but not differentiation, which was provided by CS instead. In a 
recently study, osteoblasts were found to be not able to 
proliferate on CS NFs [3]. For differentiation, stem cells 
attaching on calcium phosphate cement-chitosan scaffolds 
were successfully differentiated down the osteogenic lineage 
and expressed elevated levels of the bone marker ALP, 
indicating CS promoted osteogenic differentiation [4]. These 
findings are consistent with our results and points out the 
importance of using a blend system for preparing NFs, which 
can provide composite NFs suitable for both proliferation and 
differentiation of osteoblast cells.    
In conclusion, we have successfully fabricated electrospun 
beads-free SF/CS blend NFs covering the whole range of CS 
content. The MTS and ALP assays showed that SF enhanced 
hFOB proliferation and CS enhanced hFOB differentiation. 
Those SF/CS blend NFs will be suitable for bone tissue 
engineering applications.  
REFERENCES 
[1] B.D. Li, and Y. Xia, “Electrospinning of nanofibers: Reinventing the 
wheel?” Advanced Materials, vol. 16, pp. 1151-1170, 2004. 
[2] X. Zhang, M. Reagan, and D.L. Kaplan, “Electrospun silk biomaterial 
scaffolds for regenerative medicine,” Advanced Drug Delivery Reviews, 
vol. 61, pp. 988-1006, 2009. 
[3] P. Sangsanoh, P. Sangsanoh, O. Suwantong, A. Neamnark, P. 
Cheepsunthorn, P. Pavasant, and P. Supaphol, “In vitro biocompatibility 
of electrospun and solvent-cast chitosan substrata towards Schwann, 
osteoblast, keratinocyte and fibroblast cells,” European Polymer Journal, 
vol. 46, pp. 428-440, 2010. 
[4] J.L. Moreau, and H.K. Xu, Biomaterials, vol. 30, pp. 2675-2682, 2009. 
 
 
              (A)                                        (B)                                     (C)             
 
             (D)                                       (E)                                        
 
Fig. 1. SEM micrographs of electrospun SF/CS nanofibers with different CS 
contents. (A) 0% CS, (B) 25% CS, (C) 50% CS, (D) 75% CS, and (E) 100% 
CS. Bar = 20 μm. 
 
 
                       (A)                                                            (B)                      
 
Fig. 2. SEM micrographs of treated SF/CS nanofibers with 50% CS after 
immersed in culture medium for (A) 5 days, and (B) 14 days. Bar = 20 μm. 
 
 Time (days)
0 14 28
R
el
at
iv
e 
M
TS
 a
ss
ay
0
1
2
3
4
5
a
b
c
d
 Time (days)
0 14 28
A
LP
 a
ss
ay
 (O
.D
. 4
05
 n
m
)
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
a
b
c
d
 
                       (A)                                                           (B)   
 
Fig. 3. (A) Cell proliferation and (B) alkaline phosphatase (ALP) activities of 
hFOB cultured on TCPS and SF/CS NFs with different CS contents. (a) 75% 
CS, (b) 50% CS, (c) 25% CS, (d) TCPS. Cell number was measured by MTS 
assays and reported as relative values with the value at day 0 taken as 1 for 
each group. 
100年度專題研究計畫研究成果彙整表 
計畫主持人：陳志平 計畫編號：100-2221-E-182-024- 
計畫名稱：複合奈米纖維膜於骨組織工程之應用 
量化 
成果項目 實際已達成
數（被接受
或已發表）
預期總達成
數(含實際已
達成數) 
本計畫實
際貢獻百
分比 
單位 
備 註 （ 質 化 說
明：如數個計畫
共同成果、成果
列 為 該 期 刊 之
封 面 故 事 ...
等） 
期刊論文 1 1 100%  
研究報告/技術報告 1 1 100%  
研討會論文 1 1 100% 
篇 
 
論文著作 
專書 0 0 0%   
申請中件數 0 0 0%  專利 已獲得件數 0 0 0% 件  
件數 0 0 0% 件  
技術移轉 
權利金 0 0 0% 千元  
碩士生 0 0 0%  
博士生 2 2 100%  
博士後研究員 0 0 0%  
國內 
參與計畫人力 
（本國籍） 
專任助理 0 0 0% 
人次 
 
期刊論文 1 1 100%  
研究報告/技術報告 0 0 0%  
研討會論文 0 0 0% 
篇 
 
論文著作 
專書 0 0 0% 章/本  
申請中件數 0 0 0%  專利 已獲得件數 0 0 0% 件  
件數 0 0 0% 件  
技術移轉 
權利金 0 0 0% 千元  
碩士生 0 0 0%  
博士生 0 0 0%  
博士後研究員 0 0 0%  
國外 
參與計畫人力 
（外國籍） 
專任助理 0 0 0% 
人次 
 
